FDA Issues New Draft Guidance on De Novo Classification Process

On Monday, 3 October 2011, the Food and Drug Administration's (FDA or "the Agency") Center for Devices and Radiological Health (CDRH) issued a draft guidance regarding the submission and review of petitions under section 513(f)(2) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), also known as the de novo classification process.

Read "FDA Issues New Draft Guidance on De Novo Classification Process


Download PDF Share Back To Listing
Loading data